Navigation Links
Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program
Date:1/20/2011

Scientific Advisory Board.  "Cognition's scientific approach is unique in the industry and has generated exciting results that the Alzheimer's research community is watching closely.  Further development of these potentially disease-modifying drugs is very welcome," Dr. Lemere continued.

About Cognition

Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain and CNS. Toxic proteins play a crucial role in a large class of diseases, and there are currently no therapeutics available to prevent or block the destructive effects of toxic oligomeric proteins.  Cognition has leveraged its scientific expertise with these difficult targets to pioneer the use of proprietary assays that emphasize functional responses and proprietary medicinal chemistry to ensure novel, high quality small-molecule drug candidates for the treatment of these diseases.  www.cogrx.com

About Golden Seeds

Golden Seeds is one of the largest angel investing groups in the country.  With locations in New York, Boston, Philadelphia and San Francisco, Golden Seeds' 150 investors assist in all phases of the investment process, providing resources and expertise.


'/>"/>
SOURCE Cognition Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Powerful Image Registration and Recognition Software Unveiled for Medical, Satellite, and Defense Imaging Industries
2. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
3. ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes
4. NeuroFocus Names John Polich, World-Renowned Scientist in Brain Function and Cognition, to Head Global NeuroLab Operations
5. Mayuka Labs R&D Centre Gets DSIR Recognition
6. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
7. Consistency, Flexibility Key in Improving Rewards & Recognition Programs
8. Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx® in Cancer Treatment Options
9. Talecris Biotherapeutics Announces Revised Record Date and Meeting Date for Special Meeting of Shareholders
10. Aratana Therapeutics Announces $20 Million Financing
11. Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Cynvenio, a cancer ... through the genomic analysis of tumor cells in the ... a web-based cancer decision support application powered by CollabRx, ... Cynvenio’s ClearID™ genomic test, Therapy Finder will provide breast ...
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Two champions ... continued their sponsorship of an annual competition for middle ... and access to, innovative STEM study. The competition presents ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... Nov. 12 AvidBiotics Corp. announced the issuance ... for generating massive diversity within precisely targeted sites ... is referred to as Diversity Generating Retroelements (DGR) ... States (#7,585,957) and in Europe (#1,173,995). UCLA ...
... Nov. 12 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS) ... and nine months ended September 30, 2009. , During ... BioMS Medical and Eli Lilly and Company (NYSE: LLY) ... commercial rights to dirucotide are returned to BioMS. , ...
... 12 Regado Biosciences, a privately held company leading ... announced that David Mazzo, PhD, CEO and President, will ... Healthcare Conference at the St. Regis Hotel in New ... 1:10pm (EST) on Tuesday, November 17 and will include ...
Cached Biology Technology:AvidBiotics Corp. Granted Key U.S. and European Patents on Unique Protein Modification Platform 2BioMS Medical Announces Third Quarter 2009 Results 2BioMS Medical Announces Third Quarter 2009 Results 3BioMS Medical Announces Third Quarter 2009 Results 4BioMS Medical Announces Third Quarter 2009 Results 5BioMS Medical Announces Third Quarter 2009 Results 6BioMS Medical Announces Third Quarter 2009 Results 7BioMS Medical Announces Third Quarter 2009 Results 8Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009 2
(Date:4/23/2014)... hungry diner ripping open a dinner roll, a fuel ... open a hydrogen molecule. Now researchers have captured a ... halves of its hydrogen feast. The view confirms previous ... catalyst work better for alternative energy uses. , This ... where the hydrogen halves end up in the structure ...
(Date:4/23/2014)... a unique rhythmic sound, recorded for decades in the ... minke whale ( Balaenoptera bonaerensis ). First described and ... it sounded like a duck, the bio-duck sound has ... but its source has remained a mystery, until now. ... deployed acoustic tags on two Antarctic minke whales in ...
(Date:4/23/2014)... in Buenos Aires yesterday, Argentina joins the European ... state. The move strengthens the ties between the ... grants Argentinian scientists access to EMBL,s world-class facilities ... "Ever since its inception, fostering excellent life science ... the core of EMBL,s mission," says EMBL Director ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Scientists identify source of mysterious sound in the Southern Ocean 2Scientists identify source of mysterious sound in the Southern Ocean 3
... of mold and other causes of Sick Building ... with The American Phytopathological Society (APS). , Sick ... which building occupants experience health problems while inside ... with SBS range from allergy attacks and asthma ...
... and taking in nutrients, plant roots secrete a ... roots, as well as insects and microbes. But ... has not been extensively investigated—until now. Using the ... cabbage, Jorge Vivanco and co-workers at Colorado State ...
... earliest cities in northern China starting as far back ... successful rice farming combined with other crops, says University ... associate rice with Chinese agriculture, most archeologists have, until ... most important food associated with northern China. However, recent ...
Cached Biology News:What's really making you sick? Plant pathologists offer the science behind Sick Building Syndrome 2Roots Engage in Underground Chemical Warfare 2
... ml Dynabeads Mouse pan B (B220), ... antibody. For the efficient positive isolation ... directly from spleen or lymph node ... on mouse B cells and lytically ...
POU domain, class 2, transcription factor 2,...
IKKbeta/IKK-2 Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Reacts with human. Tested in Western blotting....
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Biology Products: